Research graph
References from Discovery of C-12 dithiocarbamate andrographolide analogues as inhibitors of SARS-CoV-2 main protease: In vitro and in silico studies. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1038/s41579-018-0118-9
10.1038/s41579-018-0118-9 · External reference
10.1053/j.gastro.2020.02.055
10.1053/j.gastro.2020.02.055 · External reference
Organ-specific manifestations of COVID-19 infection
10.1007/s10238-020-00648-x · 2020 · External reference
10.1371/journal.ppat.1009037
10.1371/journal.ppat.1009037 · External reference
10.1038/s41586-020-2012-7
10.1038/s41586-020-2012-7 · External reference
10.1021/acscentsci.1c00120
10.1021/acscentsci.1c00120 · External reference
10.1038/s41576-021-00408-x
10.1038/s41576-021-00408-x · External reference
10.1016/s0140-6736(21)02758-6
10.1016/s0140-6736(21)02758-6 · External reference
10.1038/s41586-020-2008-3
10.1038/s41586-020-2008-3 · External reference
10.1002/jmv.25681
10.1002/jmv.25681 · External reference
Coronavirus biology and replication: implications for SARS-CoV-2
10.1038/s41579-020-00468-6 · 2021 · External reference
10.1016/j.bmcl.2020.127377
10.1016/j.bmcl.2020.127377 · External reference
10.3390/microorganisms8081250
10.3390/microorganisms8081250 · External reference
10.1038/s41586-020-2223-y
10.1038/s41586-020-2223-y · External reference
Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease
10.1038/s41467-020-18709-w · 2020 · External reference
Structural plasticity of SARS-CoV-2 3CL Mpro active site cavity revealed by room temperature X-ray crystallography
10.1038/s41467-020-16954-7 · 2020 · External reference
10.1021/acscombsci.0c00058
10.1021/acscombsci.0c00058 · External reference
Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
10.1126/science.abb3405 · 2020 · External reference
Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
10.1126/science.abb4489 · 2020 · External reference
10.1021/acs.jnatprod.5b01055
10.1021/acs.jnatprod.5b01055 · External reference
10.3390/antiox8120571
10.3390/antiox8120571 · External reference
Overview of pharmacological activities of Andrographis paniculata and its major compound andrographolide
10.1080/10408398.2018.1501657 · 2019 · External reference
Experimental and clinical pharmacology of Andrographis paniculata and its major bioactive phytoconstituent andrographolide
10.1155/2013/846740 · 2013 · External reference
Broad-spectrum antiviral properties of andrographolide
10.1007/s00705-016-3166-3 · 2017 · External reference
10.1155/2014/274905
10.1155/2014/274905 · External reference
Andrographis paniculata in the treatment of upper respiratory tract infections: A systematic review of safety and efficacy
10.1055/s-2004-818938 · 2004 · External reference
Andrographis paniculata (Burm. f.) wall. ex nees: An updated review of phytochemistry, antimicrobial pharmacology, and clinical safety and efficacy
2021 · External reference
10.1080/07391102.2020.1778537
10.1080/07391102.2020.1778537 · External reference
Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: an in silico approach
2021 · External reference
Active compounds activity from the medicinal plants against SARS-CoV-2 using in silico assay
10.13005/bpj/1953 · 2020 · External reference
10.1080/07391102.2020.1777901
10.1080/07391102.2020.1777901 · External reference
Andrographolide and its fluorescent derivative inhibit the main proteases of 2019-nCoV and SARS-CoV through covalent linkage
10.1016/j.bbrc.2020.08.086 · 2020 · External reference
Anti-SARS-CoV-2 activity of Andrographis paniculata extract and its major component andrographolide in human lung epithelial cells and cytotoxicity evaluation in major organ cell representatives
10.1021/acs.jnatprod.0c01324 · 2021 · External reference
Polypharmacology of andrographolide: Beyond one molecule one target
10.1039/d0np00049c · 2021 · External reference
10.1016/j.apsb.2016.06.003
10.1016/j.apsb.2016.06.003 · External reference
Design and synthesis of C-12 dithiocarbamate andrographolide analogues as an anticancer agent
10.1016/j.bmcl.2020.127263 · 2020 · External reference
10.1016/j.csbj.2021.05.053 · Admitted local publication
10.1016/j.jmb.2006.11.073
10.1016/j.jmb.2006.11.073 · External reference
10.1016/0006-2952(73)90196-2
10.1016/0006-2952(73)90196-2 · External reference
Unresolved reference
External reference
10.1021/acs.biochem.0c00160
10.1021/acs.biochem.0c00160 · External reference
3.0: Automating pK prediction and the preparation of biomolecular structures for atomistic molecular modeling and simulations
10.1093/nar/gks375 · 2012 · External reference
10.1021/acscatal.0c03420
10.1021/acscatal.0c03420 · External reference
Unresolved reference
2009 · External reference
Screening of hepatitis C NS5B polymerase inhibitors containing benzothiadiazine core: a steered molecular dynamics
10.1080/07391102.2016.1193444 · 2017 · External reference
Structural basis of specific glucoimidazole and mannoimidazole binding by Os3BGlu7
10.3390/biom10060907 · 2020 · External reference
Unresolved reference
External reference
10.1002/jcc.20035
10.1002/jcc.20035 · External reference
10.1021/acs.jctc.9b00591
10.1021/acs.jctc.9b00591 · External reference
Software news and update AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading
10.1002/jcc.21334 · 2010 · External reference
Software news and updates AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
10.1002/jcc.21256 · 2009 · External reference
10.1021/jz501780a
10.1021/jz501780a · External reference
10.1002/wcms.1121
10.1002/wcms.1121 · External reference
10.1063/1.464397
10.1063/1.464397 · External reference
10.1016/0021-9991(77)90098-5
10.1016/0021-9991(77)90098-5 · External reference
10.1063/1.448118
10.1063/1.448118 · External reference
Synchronization of trajectories in canonical molecular-dynamics simulations: Observation, explanation, and exploitation
10.1063/1.1667473 · 2004 · External reference
10.1021/ct400341p
10.1021/ct400341p · External reference
MMPBSA.py: An efficient program for end-state free energy calculations
10.1021/ct300418h · 2012 · External reference
10.1021/jacs.1c08402
10.1021/jacs.1c08402 · External reference
10.1021/acs.jmedchem.9b01828
10.1021/acs.jmedchem.9b01828 · External reference
10.1074/jbc.m807947200
10.1074/jbc.m807947200 · External reference
10.1021/jm0603926
10.1021/jm0603926 · External reference
Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against Mpro and cathepsin L
2020 · External reference
10.1021/acs.jcim.1c00263
10.1021/acs.jcim.1c00263 · External reference
10.1021/acs.jcim.1c00404
10.1021/acs.jcim.1c00404 · External reference
10.1002/med.21862
10.1002/med.21862 · External reference
10.1002/prot.20033
10.1002/prot.20033 · External reference
10.1021/j100058a043
10.1021/j100058a043 · External reference
10.1073/pnas.80.21.6571
10.1073/pnas.80.21.6571 · External reference
10.1016/j.molliq.2020.114999
10.1016/j.molliq.2020.114999 · External reference
Rational approach toward COVID-19 main protease inhibitors via molecular docking, molecular dynamics simulation and free energy calculation
10.1038/s41598-020-74468-0 · 2020 · External reference
10.1039/d1cp04361g
10.1039/d1cp04361g · External reference
10.1021/acs.jcim.0c00491
10.1021/acs.jcim.0c00491 · External reference
Comparison of radii sets, entropy, QM methods, and sampling on MM-PBSA, MM-GBSA, and QM/MM-GBSA ligand binding energies of F. tularensis enoyl-ACP reductase (FabI)
10.1002/jcc.24011 · 2015 · External reference
10.1038/s41467-020-18233-x
10.1038/s41467-020-18233-x · External reference
Telaprevir is a potential drug for repurposing against SARS-CoV-2: computational and in vitro studies
10.1016/j.heliyon.2021.e07962 · 2021 · External reference
Computational discovery of small drug-like compounds as potential inhibitors of SARS-CoV-2 main protease
10.1080/07391102.2020.1792989 · 2020 · External reference
10.1021/acs.jcim.0c01457
10.1021/acs.jcim.0c01457 · External reference
10.1002/med.21783
10.1002/med.21783 · External reference
10.1016/j.bmcl.2007.08.031
10.1016/j.bmcl.2007.08.031 · External reference
10.1038/nbt.2786
10.1038/nbt.2786 · External reference
10.3390/ijms22179124
10.3390/ijms22179124 · External reference
Halogenated baicalein as a promising antiviral agent toward SARS-CoV-2 main protease
10.1021/acs.jcim.1c01304 · 2022 · External reference
